BBVA €1.1 billion asset-backed notes offering
Davis Polk advised Banco Bilbao Vizcaya Argentaria, S.A. on the offering of asset-backed notes with an aggregate face value amount of approximately €1.1 billion issued by BBVA Consumer Auto…
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Constellation Pharmaceuticals $192.5 million stock offering
Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with the $192.5 million offering of common stock of Constellation…
Millicom £50 million sale of shares in Helios Towers
Davis Polk has advised Millicom Holding, B.V., a subsidiary of Millicom International Cellular SA, on the sale of 25% of its holding in Helios Towers plc for gross proceeds of approximately…
Seagate HDD Cayman $500 million exchange offers
Davis Polk advised the lead dealer managers in connection with the Rule 144A/Regulation S exchange offers by Seagate HDD Cayman pursuant to which it issued $500 million aggregate…
Shockwave Medical $89.4 million stock offering
Davis Polk advised Shockwave Medical, Inc. on its SEC-registered public offering of 1,955,000 shares of common stock for an aggregate price to the public of approximately $89.4 million,…
Trebia Acquisition $517.5 million IPO
Davis Polk advised the underwriters in connection with the initial public offering of 51,750,000 units of Trebia Acquisition Corp., including 6,750,000 units purchased pursuant to the…
Via Varejo R$4.5 billion equity offering
Davis Polk advised the joint bookrunners on the equity offering of common shares of Via Varejo S.A. for an aggregate amount of approximately R$4.5 billion (approximately $860 million). The…
Ocado Group £1 billion offerings of ordinary shares and convertible bonds
Davis Polk advised Ocado Group plc as to U.S. law in connection with its placing of 33,163,265 new ordinary shares with existing and new institutional investors, which raised gross proceeds…
Royalty Pharma $2.5 billion IPO
Davis Polk advised Royalty Pharma plc and the selling shareholders on Royalty Pharma’s $2.5 billion initial public offering of 89,333,920 of its Class A ordinary shares, which included an…
Credo Technology Group Holding $100 million Series D funding round
Davis Polk advised Credo Technology Group Holding Ltd on its private placement of approximately $100 million in shares of its Series D preferred stock.Credo is a leading provider of high…